Conference Coverage
Conference Coverage
Consider Atrial Fibrillation in Patients With Stroke and Obstructive Sleep Apnea
BALTIMORE—Patients with stroke and obstructive sleep apnea (OSA) are more likely than patients without these conditions...
Conference Coverage
Signs point to growing abuse of gabapentinoids in the U.S.
LAS VEGAS – Several states have made gabapentin a Schedule V controlled substance while others have mandatory reporting of its dispensing and...
Conference Coverage
STORM trial shows response in penta-refractory myeloma
Selinexor and low-dose dexamethasone produced a “clinically meaningful benefit” in the phase 2 trial.
Conference Coverage
More than half of urine drug screens showed improper medication use
LAS VEGAS – One sample in every five showed a combination of opioids and benzodiazepines, at least one of which was an unprescribed medication.
Conference Coverage
Review protocols, follow reprocessing guidelines to cut device-related HAIs
Environmental pathogens associated with medical devices or device reprocessing are often the cause of HAI-related investigations.
Conference Coverage
The dextrose-sulfonylurea challenge: a screen for monogenetic diabetes?
ORLANDO – When investigators at Washington University, St. Louis, gave 42 patients with type 1 diabetes mellitus a dose of the sulfonylurea...
Conference Coverage
Plan now for outpatient diabetes tech in the hospital
ORLANDO – Getting ahead of the diabetes tech curve.
Conference Coverage
Intensive Blood Pressure Management May Reduce the Risk of MCI
CHICAGO—Lowering systolic blood pressure to a target of 120 mm Hg or less in people with cardiovascular risk factors reduces the risk of mild...
Conference Coverage
New MI definition aims to better distinguish infarction from injury
MUNICH – By endorsing high sensitivity cardiac troponin and cardiac MR as diagnostic cornerstones, the new MI definition stands to change U.S....
Video
ASCEND: Aspirin, fish oil flop in diabetes
MUNICH – No benefit for primary cardiovascular prevention seen in massive ASCEND trial.